Second Affiliated Hospital, Zhejiang University, School Of Medicine

This trial tests whether the Adacolumn device, which filters certain white blood cells from the blood, can reduce brain swelling in people who have had a severe stroke. Ten patients will receive the treatment within 24 hours of their stroke. The goal is to see if it prevents wors…

This trial tests whether ezetimibe, a common cholesterol-lowering medication, can reduce the return of irregular heartbeats in people with persistent atrial fibrillation who undergo catheter ablation. Half of the 120 participants will take ezetimibe daily for six months after the…

This trial tests whether rimegepant, a newer migraine medication, works as well as flunarizine, an older preventive, for reducing days with moderate-to-severe dizziness in people with vestibular migraine. About 400 adults aged 18 to 75 will take one of the two drugs daily for 12 …

This trial compares two procedures for treating severely calcified coronary arteries, a condition that makes stent placement difficult and risky. One method, rotational atherectomy, uses a tiny drill to grind away calcium, while the other, intravascular lithotripsy, uses sound wa…

This Phase 3 trial tests whether combining two drugs, tofacitinib and imatinib, can safely clear the painful pustules of palmoplantar pustulosis (PPP), a rare chronic skin disease on the palms and soles. About 135 adults with moderate-to-severe PPP will receive either the combo o…

This trial tests whether anticoagulant medications (like rivaroxaban or apixaban) are better than aspirin at preventing a second stroke in people who have had an ischemic stroke of unclear cause. Participants are adults who had a stroke within the past two weeks and show signs th…

This study is testing whether an artificial intelligence model can predict which critically ill patients in the intensive care unit (ICU) are at risk of developing multiple organ dysfunction syndrome (MODS), a serious complication where two or more organs fail. Researchers will c…

This trial investigates whether AI-assisted workflows can improve how doctors make admission diagnoses. It compares three approaches: a traditional method using standard resources, a chatbot-style AI that doctors can ask questions, and a more advanced 'agent' that automatically r…